Back to Obstetrics & Gynecology
Obstetrics & GynecologyvIOTA 2008Evidence-Based

International Ovarian Tumor Analysis (IOTA) Simple Rules Risk Assessment

Predicts risk of malignancy in adnexal masses using ultrasonographic features. The IOTA Simple Rules use 10 ultrasound features (5 benign B-rules and 5 malignant M-rules) to classify ovarian masses as benign, malignant, or inconclusive. This classification system achieves 86.8% sensitivity, 95.6% specificity, and 92.3% accuracy in distinguishing benign from malignant ovarian tumors. The rules are designed for preoperative evaluation of persistent adnexal masses in women considered for surgery, excluding classical masses with pathognomonic features (corpus luteum, endometrioma, dermoid cyst).

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
risk classification
—classification
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The International Ovarian Tumor Analysis (IOTA) Simple Rules Risk Assessment is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within obstetrics & gynecology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

If B-features present AND no M-features → Benign; If M-features present AND no B-features → Malignant; If both present OR neither present → Inconclusive

Clinical Pearls & Practice Notes

  • The IOTA Simple Rules achieved 86.8% sensitivity, 95.6% specificity, and 92.3% accuracy
  • Successfully classifies 76-80% of adnexal masses, with 10-20% remaining inconclusive
  • Developed by the International Ovarian Tumor Analysis (IOTA) group from 9 centers in 5 countries
  • B-features suggest benign etiology: B1 (unilocular cyst), B2 (solid components <7mm), B3 (acoustic shadows), B4 (smooth multilocular <100mm), B5 (no blood flow)
  • M-features suggest malignant etiology: M1 (irregular solid tumor), M2 (ascites), M3 (≥4 papillary structures), M4 (irregular multilocular ≥100mm), M5 (very strong blood flow)
  • Rules apply to persistent adnexal masses requiring surgical consideration
  • Excludes classical masses with pathognomonic features (corpus luteum, endometrioma, dermoid cyst)
  • Cannot replace proper ultrasound training and experience
  • Requires good quality ultrasound equipment and technique
  • For inconclusive cases, consider IOTA ADNEX model, expert subjective assessment, or MRI
  • Color score 1 = no blood flow, Color score 4 = very strong blood flow
  • Papillary structures are solid projections into cystic cavity from wall or septum
  • Multilocular = multiple chambers/compartments separated by septa
  • Solid components include any solid tissue within the mass
  • Irregular outline refers to non-smooth, bumpy, or lobulated contours
  • Acoustic shadows typically seen with calcifications, hair, or fat content
  • Rules designed for preoperative classification to aid surgical planning
  • High negative predictive value for benign classification reduces unnecessary oncology referrals

Evidence & Literature Citations

  1. Timmerman D, Testa AC, Bourne T, et al. Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group. J Clin Oncol. 2005 Dec 1;23(34):8794-801. doi: 10.1200/JCO.2005.01.7632.
  2. Timmerman D, Ameye L, Fischerova D, et al. Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation study. BMJ. 2010 Dec 14;341:c6839. doi: 10.1136/bmj.c6839.
  3. Nunes N, Ambler G, Foo X, et al. Use of IOTA simple rules for diagnosis of ovarian cancer: meta-analysis. Ultrasound Obstet Gynecol. 2014 Nov;44(5):503-14. doi: 10.1002/uog.13437.

Score Interpretation Ranges

Benign – pts

One or more B-features present, no M-features

Malignant – pts

One or more M-features present, no B-features

Inconclusive – pts

Both B-features and M-features present, or no features present

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.